0VAG Stock Overview
Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$174.44 |
| 52 Week High | US$187.88 |
| 52 Week Low | US$111.91 |
| Beta | 1.29 |
| 11 Month Change | -0.67% |
| 3 Month Change | 2.74% |
| 1 Year Change | 43.51% |
| 33 Year Change | 1.40% |
| 5 Year Change | n/a |
| Change since IPO | 191.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0VAG | GB Electronic | GB Market | |
|---|---|---|---|
| 7D | -1.3% | -1.7% | -1.2% |
| 1Y | 43.5% | 9.8% | 8.9% |
Return vs Industry: 0VAG exceeded the UK Electronic industry which returned 9.7% over the past year.
Return vs Market: 0VAG exceeded the UK Market which returned 8.9% over the past year.
Price Volatility
| 0VAG volatility | |
|---|---|
| 0VAG Average Weekly Movement | 5.6% |
| Electronic Industry Average Movement | 5.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0VAG has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0VAG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 2,900 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Novanta Inc. Fundamentals Summary
| 0VAG fundamental statistics | |
|---|---|
| Market cap | US$6.25b |
| Earnings (TTM) | US$62.17m |
| Revenue (TTM) | US$899.85m |
100.6x
P/E Ratio6.9x
P/S RatioIs 0VAG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0VAG income statement (TTM) | |
|---|---|
| Revenue | US$899.85m |
| Cost of Revenue | US$502.60m |
| Gross Profit | US$397.25m |
| Other Expenses | US$335.09m |
| Earnings | US$62.17m |
Last Reported Earnings
Jun 28, 2024
Next Earnings Date
Nov 05, 2024
| Earnings per share (EPS) | 1.73 |
| Gross Margin | 44.15% |
| Net Profit Margin | 6.91% |
| Debt/Equity Ratio | 68.7% |
How did 0VAG perform over the long term?
See historical performance and comparison